Multiple Sclerosis Treatments
Cost effectiveness of riluzole in amyotrophic lateral sclerosis.
Tumor necrosis factor 2 allele does not contribute to increased tumor necrosis factor-alpha production in Sardinian multiple sclerosis.
Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients trated with INF beta-1a or INF beta-1b.Autoimmune events during interferon beta-1b treatment for multiple sclerosis.
An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients.
E-selectin A561C and G98T polymorphisms influence susceptibility and progression of Multiple Sclerosis.Carotid artery atherosclerosis and risk factors for stroke in a selected population of asymptomatic men.
Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis. Crohn's disease, ulcerative colitis, psoriasis, lupus erythematosus, multiple sclerosis and migraine headaches. Tumor necrosis factor-a and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.Serum amyloid a protein is elevated in relapsingremitting multiple sclerosis.
Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis.Defective T cell fas function in patients with multiple sclerosis.
Rate of pregnancy-related relapse in Multiple Sclerosis. IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis. Defense Department operated a pilot program that gives priority to studies of existing treatments for Gulf War illnesses. Multiple sclerosis in Sardinia is associated and linked with HLA-DR3 and -DR4. Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. A high-resolution three-dimensional T1- weighted gradient-echo sequence improves the detection of disease activity in multiple sclerosis. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. Human herpes virus 6 is latent in peripheral blood of relapsing remitting multiple sclerosis patients. Systemic high-dose recombinant-alpha-2ainterferon therapy modulates lymphokine production in multiple sclerosis. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. XLOA gene will advance our understanding of the inherited optic neuropathies and perhaps suggest treatments for these diseases.SELPLG and SELP single nucleotide polymorphisms in multiple sclerosis.
Relation of cognitive impairment and depression to quality of life in multiple sclerosis patients.
Exogenous factors in the etiology of multiple sclerosis. T-lymphocyte immunointerferon receptors in patients with multiple sclerosis.Cortical silent period in patients with amyothrophic lateral sclerosis.
Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. REM sleep behavior disorders in multiple system atrophy.Prevalence of multiple sclerosis in the L'Aquila district, central Italy.
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Decreases in Tcell tumor necrosis factor alpha binding with interferon beta treatment in patients with multiple sclerosis. Lesion load quantification in serial MR of early relapsing multiple sclerosis patients in azathioprine treatment. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis. The contribution of HLA to multiple sclerosis susceptibility in Sardinian affected sibling pairs. Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.Epidemiology of multiple sclerosis in Italy and in southern Europe.
Multiple secondary Leber's hereditary optic neuropathy mutations in Italian patients with multiple sclerosis.Analytic approaches to the study of etiological factors in multiple sclerosis.
A) as post-induction therapy for responding multiple myeloma patients.
Increased Tlymphocyte interleukine-6 binding in patients with multiple sclerosis.Multiple paraneoplastic diseases associated with thymoma.
High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign cours in multiple sclerosis. T-cell interferon-gamma, tumor necrosis factor-alpha and interleukine-6 receptor binding in patients with multiple sclerosis. Neurophysiological evidence of neuroplasticity at multiple levels of thesomatosensory system in patients with carpal tunnel syndrome. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon beta-1b. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles.Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain- Barrè syndrome.
A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis.Partila depletion and multiple deletions of muscle mtDNA in familial MNGIE sindrome.
REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure.
The effect of Copolymer 1 on serial gadolinium-enhanced MRI in relapsing remitting multiple sclerosis. Prevalence and incidence of multiple sclerosis in the city of Monreale, Italy.Circadian and hypothermia-induced effects on visual and auditory evoked potentials in multiple sclerosis.
Carpal tunnel syndrome in amyotrophic lateral sclerosis and late onset cerebellar ataxia. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Multiple Sclerosis Review Group (ACTH e corticosteroidi nelle esacerbazioni; antispastici nella SM) 3.T-cell tumor necrosis factor-alpha receptor binding in patients with multiple sclerosis.
Out-Patients administration of Lateral Amiotrofic Sclerosis.
Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. GAMES, Genetic Anaysis of Multiple sclerosis in EuropeanS, Cambridge, UK 2. Smoking habits in multiple system atrophy and progressive supranuclear palsy.Analytic approaches to the study of etiological factors in multiple sclerosis.
Antinuclear antibodies and MRI activity in multiple sclerosis.
Weizmann Institute of Science nearly thirty years ago and licensed to Teva Pharmaceutical Industries (Teva) for the treatment of Multiple Sclerosis.
The increasing incidence and prevalence of multiple sclerosis in a Sardinian province.Smoking habitus in multiple system atrophy and progressive supranuclear palsy.
DNA sequences in brain multiple sclerosis patient, normal adults and children. Validation of Italian multiple sclerosis quality of life 54 questionnaire. ICAM-1 gene is not associated with multiple sclerosis in Sardinian patients.It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.
Diffusion imaging of demyelinating plaques in relapsing-remitting and secondary preogressive multiple sclerosis.
Pudendal nerve somatosensory evoked potentials in probable multiple sclerosis. The effect of interferon beta 1-b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. Neurophysiological evidence of neuroplasticity at multiple levels of the somatosensory system in patients with carpal tunnel syndrome. Fatigue and magnetic resonance imaging activity in multiple sclerosis. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with Multiple Sclerosis. T-cell interferon gamma receptor binding in interferon beta-1b treated patients with multiple sclerosis. Immunological patterns identifying disease course and evolution in multiple sclerosis patients. Siegel J Comparative effectiveness of treatments for rheumatoid arthritis. Hawkins CP & Wolinsky JS - Principles of Treatments in Multiple Sclerosis. Involvement of limbic system in multiple sclerosis patients with depressive disorders. An epidemiological study of multiple sclerosis in central Sardinia, Italy.CMT types, allowing more productive scientific exploration of possible treatments.
T-cell interleukin-6 receptor binding in interferon-beta-1b treated multiple sclerosis patients. Methodologic experience from a multicenter case - control study (on multiple sclerosis) in Italy. Verbal learning strategies in patients with multiple sclerosis. The immune response to mycobacterial 70-kd heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. The usefulness of the somatosensory evoked potentials of the pudendal nerve in diagnosis of probable multiple sclerosis. Early synthesis and correlation of serum antithyroid antibodies with clinical parameters in multiple sclerosis. A prospective study on the predictive value of cerebrospinal fluid oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.Cytokine production in patients carrying multiple sclerosis-linked HLA-DR alleles.
Cerebrospinal fluid isoprstane shows oxidative stress in patients with multiple sclerosis. RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-B-1b. Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. A third locus predisposing to multiple deletions of mtDNA in autosomal dominant progressive external ophthalmoplegia.Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis.
Induction of a non-encephalitogenic type 2 T helpercell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomised phase II trial.
An encephalitic episode in a multiple sclerosis patient with human herpesvirus 6 latent infection. R & Rieckmann P - Pathogenese und Therapie der Multiplen Sklerose.